Statins in Kidney Transplant Recipients: Usage, All-Cause Mortality, and Interactions with Maintenance Immunosuppressive Agents.

Sunjae BaeJiYoon B AhnKMDCorey JosephRyan WhislerMark A SchnitzlerKrista L LentineBernard S KadoshDorry L SegevMara A McAdams-DeMarco

Published in: Journal of the American Society of Nephrology : JASN (2023)

Real-world evidence supports statin therapy for reducing all-cause mortality in KT recipients. Effectiveness might be greater when combined with mTOR inhibitor-based immunosuppression.

Keyphrases

cardiovascular disease
randomized controlled trial
systematic review
cell proliferation
coronary artery disease
kidney transplantation
type diabetes
low density lipoprotein